Clinical Trials on Metastatic Adenocarcinoma of the Gastroesophageal Junction in Korea, Democratic People's Republic of
Total 82 results
-
Millennium Pharmaceuticals, Inc.TerminatedMetastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Recurrent Gastric Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Advanced Gastrointestinal Carcinoma | Recurrent Gastrointestinal CarcinomaTaiwan, Korea, Republic of, Japan
-
Asan Medical CenterRecruitingResectable Gastric or Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Samyang Biopharmaceuticals CorporationUnknownMetastatic Adenocarcinoma of the Pancreas | Recurrent Adenocarcinoma of the PancreasKorea, Republic of
-
Elevar TherapeuticsTerminatedGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Asan Medical CenterRecruitingGastric or Gastroesophageal Junction(GEJ) AdenocarcinomaKorea, Republic of
-
Genta IncorporatedUnknownAdenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric JunctionUnited States, Korea, Republic of
-
MedPacto, Inc.Merck Sharp & Dohme LLCActive, not recruitingMetastatic Colorectal Cancer | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Minneamrita Therapeutics LLCRecruitingMetastatic Adenocarcinoma of the PancreasKorea, Republic of
-
Samsung Medical CenterCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Eli Lilly and CompanyNo longer availableMetastatic Gastric Cancer | Metastatic Adenocarcinoma of the Gastroesophageal JunctionGermany, Netherlands, Austria, Greece, Korea, Republic of
-
Artiva Biotherapeutics, Inc.Not yet recruitingBreast Cancer | Gastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
Yonsei UniversityRecruitingAdenocarcinoma of the ColonKorea, Republic of
-
Genome & CompanyMerck KGaA, Darmstadt, GermanyActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Hallym University Medical CenterNot yet recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
National Cancer Center, KoreaKorean Cancer Study GroupRecruiting
-
Hallym University Medical CenterCompletedGastric or Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
Konkuk University Medical CenterCompletedThis Study Was Focused to Evaluate Feasibility of Doppler Tissue Monitoring During the Induction Anesthesia, | and Evaluate Routine Propofol Induction's Effect on Myocardial Tissue Motion, Using Non-invasive Doppler Tissue and 2D Speckle Tracking Imaging. | This is the First Study,...Korea, Republic of
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
AmgenTerminatedGastric and Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Yonsei UniversityEnrolling by invitationAdenocarcinoma of the ColonKorea, Republic of
-
Samsung Medical CenterUnknownRecurrent or Metastatic Salivary Gland Cancer of the Head and NeckKorea, Republic of
-
MedImmune LLCCompletedGastric or Gastroesophageal Junction AdenocarcinomaCanada, United States, Taiwan, Korea, Republic of, Japan, Singapore
-
Gangnam Severance HospitalCompletedColorectal Cancer Metastatic | Pseudomyxoma Peritonei | Appendiceal Neoplasm | Cancer Metastatic to the Peritoneal CavityKorea, Republic of
-
Toray Industries, IncRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Japan
-
TORL Biotherapeutics, LLCTranslational Research in OncologyRecruitingGastric Cancer | Advanced Solid Tumor | Pancreas Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
TORL Biotherapeutics, LLCTranslational Research in OncologyRecruitingGastric Cancer | Advanced Solid Tumor | Pancreas Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
Astellas Pharma Global Development, Inc.RecruitingPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Japan, Korea, Republic of
-
Yonsei UniversityCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Spain, United Kingdom, Korea, Republic of, Canada, Japan, Malaysia, Taiwan, Singapore, Moldova, Republic of, Australia, Poland, Georgia
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
UCB Biopharma SRLRecruitingGeneralized Myasthenia GravisItaly, United States, Korea, Republic of
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingAdvanced/Metastatic Gastroesophageal AdenocarcinomaChina, Japan, Poland, Hong Kong, Korea, Republic of, Canada, United States, Argentina, Australia, Belgium, Chile, Colombia, Costa Rica, France, Germany, Guatemala, Ireland, Israel, Italy, Russian Federation, Spain, Taiwan, Turkey, United...
-
ALX Oncology Inc.Eli Lilly and CompanyRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, France, Korea, Republic of, Taiwan, United Kingdom, Japan, Singapore, Belgium, Czechia, Italy
-
Hoffmann-La RocheBioLineRx, Ltd.; Halozyme TherapeuticsActive, not recruitingGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaUnited States, United Kingdom, Australia, Korea, Republic of, Taiwan, Israel, Spain
-
Merck Sharp & Dohme LLCTerminatedGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaChina, Korea, Republic of, Malaysia, Taiwan
-
Asan Medical CenterUnknownStomach Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Duodenal Cancer | Esophagogastric Junction Cancer | Cancer-associated Thrombosis | Ampulla of Vater Cancer | Malignant Gastrointestinal Stromal Tumor | Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Korea, Republic of
-
Eli Lilly and CompanyAstraZenecaCompletedHepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
-
IpsenActive, not recruitingMetastatic Adenocarcinoma of the PancreasUnited States, Spain, Hungary, France, Portugal, Korea, Republic of, Germany, United Kingdom, Austria, Italy, Israel, Australia, Brazil, Czechia, Belgium, Russian Federation, Canada, Greece
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced Colorectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States, Australia, Belgium, Brazil, Canada, Czech Republic, Greece, Korea, Republic of, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Cancer | Gastroesophageal Junction CancerUnited States, Belgium, Brazil, Canada, Chile, China, Estonia, France, Germany, Guatemala, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Philippines, Poland, Russian Federation, Singapore, Taiwan, Ukraine, United...